Sirt1 Activation by Post-ischemic Treatment With Lumbrokinase Protects Against Myocardial Ischemia-Reperfusion Injury

Overview of attention for article published in Frontiers in Pharmacology, June 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 13 X posts from 7 X users, with an upper bound of 19,653 followers.

Sirt1 Activation by Post-ischemic Treatment With Lumbrokinase Protects Against Myocardial Ischemia-Reperfusion Injury. https://t.co/xRnxWEVyjy

17 Jun 2023

Reply Repost Favourite

RT @renesugar: Sirt1 Activation by Post-ischemic Treatment With Lumbrokinase Protects Against Myocardial Ischemia-Reperfusion Injury https…

05 May 2023

Reply Repost Favourite

@MVGutierrezMD Reversing lung fibrosis is on the long list of possible beneficial effects of metformin. Nattokinase, lumbrokinase (eg. Boluoke), etc. could also be useful. https://t.co/H9bbkPBBWY https://t.co/z3dUgOp8N7

03 May 2023

Reply Repost Favourite

https://t.co/H9bbkPBBWY "Moreover, post-ischemic treatment with lumbrokinase activates Sirt1 and induces FoxO1 deacetylation, which enhances autophagic flux and reduces oxidative damage, inflammation and apoptosis after myocardial I-R-injury."

28 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.